Novel Models of CF Mucus Plugs for Testing Phage and Tailocin Therapy – Gregory Burkeen, PhD Candidate

Gregory Burkeen, a PhD Candidate at San Diego State University in Drs. Anca Segall and Forest Rohwer’s labs, presents results from CFRI-funded research on novel models of CF mucus plugs for testing phage and tailocin therapy. He proposes an in-vitro model based on artificial sputum that is tailored to the individual, and can be used to test the safety and efficacy of personalized therapeutic regimens. This presentation was part of CFRI's Virtual 35th National CF Education Conference.

CFRI's 35th National CF Education Conference was sponsored by Vertex Pharmaceuticals, Genentech, Gilead Sciences, Chiesi USA, AbbVie, and Ionis Pharmaceuticals.